X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TTK HEALTHCARE 2017-18 Annual Report Analysis

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE 2017-18 Annual Report Analysis
Wed, 27 Mar

TTK HEALTHCARE has announced its results for the year ended March 2018. Let us have a look at the detailed performance review of the company during FY17-18.

TTK HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 9.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 10.6% YoY during the fiscal. Operating profit margins witnessed a fall and down at 7.4% in FY18 as against 7.3% in FY17.
  • Depreciation charges increased by 27.9% and finance costs increased by 52.1% YoY, respectively.
  • Other income grew by 32.1% YoY.
  • Net profit for the year declined by 3.0% YoY.
  • Net profit margins during the year declined from 3.5% in FY17 to 3.1% in FY18.

TTK HEALTHCARE Income Statement 2017-18

No. of Mths Year Ending12 Mar-17*12 Mar-18*% Change
Net SalesRs m5,2785,7769.4%
Other incomeRs m577632.1%
Total RevenuesRs m5,3355,8519.7%
Gross profitRs m38542610.6%
DepreciationRs m11915227.9%
InterestRs m314752.1%
Profit before taxRs m2923023.3%
TaxRs m10412014.8%
Profit after taxRs m187182-3.0%
Gross profit margin%7.37.4
Effective tax rate%35.839.7
Net profit margin%3.53.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



TTK HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY18 stood at Rs 2 billion as compared to Rs 1 billion in FY17, thereby witnessing an increase of 39.9%.
  • Long-term debt down at Rs 7 million as compared to Rs 9 million during FY17, a fall of 24.1%.
  • Current assets rose 53% and stood at Rs 3 billion, while fixed assets rose 11% and stood at Rs 1 billion in FY18.
  • Overall, the total assets and liabilities for FY18 stood at Rs 4 billion as against Rs 3 billion during FY17, thereby witnessing a growth of 43%.

TTK HEALTHCARE Balance Sheet as on March 2018

No. of Mths Year Ending12 Mar-17*12 Mar-18*% Change
NetworthRs m1,5752,33047.9
 
Current LiabilitiesRs m1,1971,67539.9
Long-term DebtRs m97-24.1
Total LiabilitiesRs m2,8494,07343.0
 
Current assetsRs m1,6662,55653.5
Fixed AssetsRs m 9951,10310.9
Total AssetsRs m2,8494,07343.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



TTK HEALTHCARE Cash Flow Statement Analysis

  • TTK HEALTHCARE's cash flow from operating activities (CFO) during FY18 stood at Rs 253 million, an improvement of 42.1% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY18 stood at Rs -226 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY18 stood at Rs -72 million, an improvement of 69% on a YoY basis.
  • Overall, net cash flows for the company during FY18 stood at Rs -41 million from the Rs 1 million net cash flows seen during FY17.

TTK HEALTHCARE Cash Flow Statement 2017-18

ParticularsNo. of months1212% Change
Year EndingMar-17Mar-18
Cash Flow from Operating ActivitiesRs m17825342.1%
Cash Flow from Investing ActivitiesRs m53-226-
Cash Flow from Financing ActivitiesRs m-229-72-
Net Cash FlowRs m1-41-
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Current Valuations for TTK HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 12.9, an decline from the EPS of Rs 24.1 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 675.0, stands at 19.1 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 6.8 times, while the price to sales ratio stands at 2.8 times.
  • The company's price to cash flow (P/CF) ratio stood at 15.7 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending12 Mar-17*12 Mar-18*
Sales per share (Unadj.)Rs679.3408.7
TTM Earnings per shareRs24.112.9
Diluted earnings per shareRs24.123.4
Price to Cash Flow x17.115.7
TTM P/E ratiox19.119.1
Price / Book Value ratiox4.66.8
Market CapRs m5,2455,245
Dividends per share (Unadj.)Rs5.05.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Ratio Analysis for TTK HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.5x during FY18, from 1.4x during FY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 7.4x during FY18, from 10.4x during FY17. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 7.8% during FY18, from 11.9% during FY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 14.9% during FY18, from 20.4% during FY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 5.6% during FY18, from 7.7% during FY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending12 Mar-17*12 Mar-18*
Current ratiox1.41.5
Debtors’ DaysDays2435
Interest coveragex10.47.4
Debt to equity ratiox0.00.0
Return on assets%7.75.6
Return on equity%11.97.8
Return on capital employed%20.414.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



To see how TTK HEALTHCARE has performed over the last 5 years, please visit here.

TTK HEALTHCARE Share Price Performance

Over the last one year, TTK HEALTHCARE share price has moved up from Rs 1,066.4 to Rs 675.0, registering a loss of Rs 391.4 or around 36.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,248.9 (up 0.3%). Over the last one year it has moved up from 13,308.8 to 14,248.9, a gain of 940 points (up 7.1%).

(To know more, check out historical annual results for TTK HEALTHCARE and quarterly results for TTK HEALTHCARE)

Equitymaster requests your view! Post a comment on "TTK HEALTHCARE 2017-18 Annual Report Analysis". Click here!

  

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - BIOCON COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS